Molecular profiling and genetic testing have revolutionised lung cancer treatment, says a doctor. They have enabled targeted therapies that are more effective and tolerable than traditional ...
Shanghai Henlius Biotech, Inc. (2696.HK) announced that its anti-PD-1 mAb, HANSIZHUANG (serplulimab, marketed as Hetronifly® in Europe), has been officially approved by the European Commission (EC) ...
Combination Treatment Improves Response to Immunotherapy for Lung Cancer Sep. 25, 2024 — Researchers have tested a combination of treatments in mice with lung cancer and shown that these allow ...